Dictionary

allow_url_fopen is ENABLED Dictionary Search

vanda

Synonyms

Noun

1. orchid

2. orchidaceous plant

Usage
Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder - Stocktwits
Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises - Investing.com
Vanda Dean Lyman Obituary (2026) - Elm Springs, AR - Memorial Funeral Home - Springdale - Legacy obituary
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results - PR Newswire
Vanda (NASDAQ: VNDA) investors approve directors, auditor and equity plan shares - Stock Titan
How The Vanda Pharmaceuticals (VNDA) Investment Story Is Shifting With BYSANTI And Nereus - Yahoo Finance
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - PR Newswire
Vanda Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright - Investing.com
Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years - PR Newswire
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods - PR Newswire
Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors - PR Newswire
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence - PR Newswire
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - PR Newswire
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder - PR Newswire
Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines - PR Newswire
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - PR Newswire
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation - PR Newswire
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire
Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Retail investors fuel record buying in US software ETF as AI trade broadens - The Mighty 790 KFGO
Tribute Wall | Vanda Simmons - floralhaven.com
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results - PR Newswire
Vanda initiates study of motion sickness drug Nereus in GLP-1 users - Fierce Pharma
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PR Newswire
Vanda Ree Kapulani Fields Obituary March 12, 2026 - Gate City Funeral Home
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus - Pharmaceutical Technology
Dr. Vanda Corbett - Focused Ultrasound Foundation
Vanda Pharmaceuticals Becomes Presenting Sponsor of Men’s Basketball Season and Smith Center Celebration - George Washington University Athletics
FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid - Fierce Pharma
FDA Accepts Vanda Pharmaceuticals’ BLA for Imsidolimab in Generalized Pustular Psoriasis - Dermatology Times
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Vanda DaCorte Morris Obituary May 6, 2026 - holcombefuneralhomes.com
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting - PR Newswire
Vanda, with FDA nod for Bysanti, gains 2nd new drug approval in as many months - Fierce Pharma
Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder - Fierce Pharma
How many employees work at Vanda Pharmaceuticals? - Revelio Labs
CHMP backs drugs from Novartis, Crinetics while Vanda gets a thumbs down - FirstWord PHARMA
Japan gives special status to Vanda drug for rare, severe skin disease - Stock Titan
Vanda's motion sickness drug, Agios' thalassemia treatment make the grade with FDA - Fierce Pharma
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration - PR Newswire
New York Islanders Name Vanda Pharmaceuticals as Team’s Jersey Patch Partner in Milestone NHL Agreement - NHL.com
US FDA approves Vanda's antipsychotic pill, shares climb - Reuters
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus - BioSpace
Biopharma bites: Vanda gets sought-after hearing, plus ICER's Entyvio report and more from Disc, QL Biopharma - FirstWord PHARMA
Vanda (VNDA) director donates 25,836 shares of common stock - Stock Titan
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug - BioSpace
Vanda Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026 - BioSpace
Watch Vanda Insights on Oil Markets, IEA Report - Bloomberg.com
US FDA Accepts Vanda Pharmaceuticals’ BLA for Imsidolimab for GPP - The Dermatology Digest
Vanda Pharmaceuticals Signs on as Sponsorship Partner for Georgetown Men’s and Women’s Basketball Games - Georgetown University Athletics
Kim Wijkstrom of Vanda Pharmaceuticals on the AI Revolution in Health Marketing - Muse by Clio
Why Vanda Pharmaceuticals (VNDA) Is Up 17.4% After Rare FDA Hearing Granted On HETLIOZ Jet Lag - Yahoo Finance
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness - PR Newswire
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder - PR Newswire
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - PR Newswire
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena - PR Newswire
US FDA approves Vanda Pharmaceuticals' motion sickness drug - Reuters
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference - PR Newswire
Vanda a new buy at B. Riley on 'historic discount' - MSN
FDA lifts partial hold on Vanda’s motion sickness drug following dispute resolution - FirstWord PHARMA
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley - Yahoo Finance
After court win, Vanda reaches accord with FDA on Hetlioz, tradipitant reviews - FirstWord PHARMA
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag - BioSpace
Vanda and the FDA make nice, agreeing to squash several disputes following appeals court win - Fierce Pharma
Vanda Pharmaceuticals Q3 Earnings Preview - MSN
Vanda Orchid Thai Bistro Reflects on Five Years - Independent Voice |
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - Yahoo Finance
Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences - Yahoo Finance
Vanda signs on as NHL's 1st pharma patch sponsor in Islanders deal, inks DC arena partnership - Fierce Pharma
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - Quantisnow
Vanda Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Vanda's tradipitant halves vomiting rate in patients taking Wegovy - FirstWord PHARMA
Vanda Pharmaceuticals, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Has Vanda Pharmaceuticals Finally Found Its Game-Changer with Bysanti - Kavout
FDA again rejects Vanda's Hetlioz for jet lag disorder - FirstWord PHARMA
Capitals Announce Vanda Pharmaceuticals as Official Zamboni Partner | Washington Capitals - NHL.com
Vanda Files BLA for Imsidolimab in Generalized Pustular Psoriasis - Dermatology Times
Assessing Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of NEREUS For Motion Sickness - Yahoo Finance
Vanda Research Says Retail Investors are Buying the Tesla Stock Dip. Should you? - Yahoo Finance
FDA clock runs slightly longer on re-review of hold on Vanda's tradipitant - FirstWord PHARMA
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - PR Newswire
State Street (VNDA) discloses 3.02M shares, 5.1% ownership on 13G - Stock Titan
D.C.'s Vanda Pharmaceuticals launches first new prescription motion sickness drug in decades - The Business Journals
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley - Yahoo Finance
Vanda Sues FDA Over Suspended Drug Study for Stomach Disorder - Bloomberg Law News
Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA) - Seeking Alpha
Vanda Pharmaceuticals (NASDAQ: VNDA) boosts 2026 revenue view on new approvals - Stock Titan
Vanda Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Vanda Stock Drops 10% Premarket After FDA Rejects Jet Lag Drug Application - Stocktwits
Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline By Investing.com - Investing.com Nigeria
Vanda Marie Rigsby Obituary October 21, 2025 - Music Funeral Services
Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" - PR Newswire
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - Barchart.com
Vanda and Exante Data Combine in Strategic Merger - Business Wire
Vanda Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Vanda Pharmaceuticals surges as FDA approves Bysanti for bipolar I disorder and schizophrenia - Quiver Quantitative
Vanda sets May 6 earnings release, investor call after market close - Stock Titan
A story with heart: How Vanda Ayrapetyan is championing children’s literacy in Armenia - The Armenian Weekly
Foreign Language Equivalents
Foreign Language Equivalents of 'vanda'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
vnada,   vands,   banda,   vabda,   vandda,   canda,   vadna,   vana,   avnda,   vanfa,   vandaa,   anda,   vada,   vansa,   vsnda,   vannda,   vaanda,   vnda,   vand,   vamda,   vvanda,   vanad
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z